Figure 1.
Correlation between serum levels of soluble MUC1 and anti-MUC1 TRA or SP autoantibodies. Soluble MUC1 levels in 14 multiple myeloma patients with progressive disease under therapy, were correlated with the serum levels of anti-MUC1 TRA autoantibodies (A) and anti-MUC1 SP autoantibodies (B). A significant positive correlation (R2=0.5361, P<0.048, Pearson correlation coefficient) was found only between the serum levels of sMUC1 and anti-MUC1 SP autoantibodies.